Feline models of type 2 diabetes mellitus (Q36521109)

14 August 2017

1 reference

title

Feline models of type 2 diabetes mellitus (English)

1 reference

14 August 2017

1 reference

Michael S Henson

1

1 reference

PubMed ID

16804198

14 August 2017

Timothy D O'Brien

series ordinal

2

1 reference

14 August 2017

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

47

1 reference

14 August 2017

234-242

1 reference

14 August 2017

3

1 reference

Determination of reference values for glucose tolerance, insulin tolerance, and insulin sensitivity tests in clinically normal cats

14 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Insulin sensitivity decreases with obesity, and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Electrophysiologic measures of diabetic neuropathy: mechanism and meaning

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Genetics of Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Nerve biopsy and conduction studies in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Diabetic neuropathies: a statement by the American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Intraretinal pH in diabetic cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Effects of weight gain and loss on metabolic rate, glucose tolerance, and serum lipids in domestic cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Enhanced superoxide radical production by stimulated polymorphonuclear leukocytes in a cat model of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

High glucose concentration favors the selective secretion of islet amyloid polypeptide through a constitutive secretory pathway in human pancreatic islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Heterogeneity of insulin responses: phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Impaired glucose tolerance in the U.S. population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Intracellular amyloidogenesis by human islet amyloid polypeptide induces apoptosis in COS-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Influence of glucose dosage on interpretation of intravenous glucose tolerance tests in lean and obese cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

A feline model of experimentally induced islet amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Islet amyloid and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Longitudinal studies on the development of diabetes in individual Macaca nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Neutrophil count and activation in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Genetic models for non insulin dependent diabetes mellitus in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

A novel assay in vitro of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Rat amylin: cloning and tissue-specific expression in pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Neurological complications associated with spontaneously occurring feline diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Myelin splitting, Schwann cell injury and demyelination in feline diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Pathogenesis of feline diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

High dose intravenous glucose tolerance test and serum insulin and glucagon levels in diabetic and non-diabetic cats: relationships to insular amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Islet Amyloid Polypeptide and Insulin Secretion From Isolated Perfused Pancreas of Fed, Fasted, Glucose-Treated, and Dexamethasone-Treated Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Decreased polymorphonuclear leukocyte deformability in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

21 January 2018

Acromegaly in 14 cats

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

The global spread of type 2 diabetes mellitus in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Ion Channels and Insulin Secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Over representation of Burmese cats with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Aldose reductase activity and glucose-related opacities in incubated lenses from dogs and cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Emerging epidemic of type 2 diabetes in youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Amyloid peptides are toxic via a common oxidative mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Experimental diabetic neuropathy: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

The sulphonylurea receptor may be an ATP-sensitive potassium channel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Diabetes mellitus and bilateral cataracts in a kitten

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance: 4-year results from the Finnish Diabetes Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

The neurological and metabolic effects of streptozotocin in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

Sural nerve pathology in diabetic patients with minimal but progressive neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.47.3.234

21 January 2018

Identifiers

DOI

10.1093/ILAR.47.3.234

1 reference

release_dttze5jpwjeife5ydosqmqfxtm

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dttze5jpwjeife5ydosqmqfxtm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16804198

1 reference

PubMed ID

16804198